TIANJIN TIANYAO PHARMACEUTICALS CO LTD

Overview

TIANJIN TIANYAO PHARMACEUTICALS CO LTD is an active pharmaceutical ingredient (API) supplier with 55 active FDA Type II Drug Master Files, covering 21 S ARGATROBAN; 7-AVCA; ABIRATERONE ACETATE; ALPROSTADIL; AMBRISENTAN; BELINOSTAT.

API / Drug Master Files

TIANJIN TIANYAO PHARMACEUTICALS CO LTD holds 55 active (57 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TREPROSTINILActive2025-09-04
• DINOPROSTONEActive2025-07-07
• VILDAGLIPTINActive2024-06-05
• CARBOPROST TROMETHAMINEActive2021-10-14
• DEFLAZACORT BULK APIActive2021-04-26
• BETAMETHASONE DIPROPIONATE USPActive2020-12-24
• FLUOCINONIDE, USPActive2020-11-26
• HYDROCORTISONE, USPActive2020-11-26
• DEXAMETHASONE BULK APIActive2020-08-24
• DEXAMETHASONE SODIUM PHOSPHATE, BULK APIActive2020-08-21
• ALPROSTADILActive2020-04-21
• FLUTICASONE PROPIONATE USPActive2019-12-17
• MOMETASONE FUROATE MONOHYDRATE BULK APIActive2019-12-17
• BETAMETHASONE USP BULK APIActive2019-09-25
• TREPROSTINIL DIETHANOLAMINEActive2017-12-06

Showing 15 of 57 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to TIANJIN TIANYAO PHARMACEUTICALS CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.